Company Filing History:
Years Active: 1998-1999
Title: Anne Mary Freeman: Innovator in Soluble CR1 Derivatives
Introduction
Anne Mary Freeman is a notable inventor based in Wendover, GB. She has made significant contributions to the field of biotechnology, particularly in the development of soluble polypeptides. With a total of 2 patents to her name, Freeman's work is recognized for its innovative approach to complement receptor research.
Latest Patents
Freeman's latest patents focus on soluble CR1 derivatives. These patents provide soluble polypeptides that comprise no more than three short consensus repeats (SCR) of Complement Receptor 1, specifically containing SCR3. Additionally, the patents include DNA molecules encoding such soluble polypeptides, as well as methods, vectors, and host cells related to their use.
Career Highlights
Freeman is currently associated with Adprotech Limited, where she continues to advance her research and development efforts. Her work has been instrumental in exploring the applications of soluble CR1 derivatives in various biotechnological contexts.
Collaborations
Throughout her career, Freeman has collaborated with esteemed colleagues, including Danuta Ewa Mossakowska and Ian Dodd. These partnerships have contributed to the success and impact of her research initiatives.
Conclusion
Anne Mary Freeman stands out as an influential inventor in the field of biotechnology, with her innovative work on soluble CR1 derivatives paving the way for future advancements. Her contributions continue to inspire and shape the landscape of scientific research.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.